
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Interview: Intergrating clinical trial results into managed care practice
Author(s)John R. Rodgers, RPh, MBA
Advertisement
Articles in this issue
almost 23 years ago
NCEP ATP III guidelines incorporate global risk assessmentalmost 23 years ago
Case reports illustrate consequences of ATP III in practicealmost 23 years ago
Inflammatory markers are useful risk assessment toolsalmost 23 years ago
IVUS is redefining atherosclerotic diseaseAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
3
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
4
Social Factors Shape Diabetes, Dementia Risk Across Populations
5




